Lexicon Pharmaceuticals | LXRX - 普通株資本





普通株資本 変化する 日付
Abbott USD 1.74B 2.94M 2026-03
Acadia Pharmaceuticals USD 172.31M 174K 2026-09
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Akebia Therapeutics USD 265.42M 199K 2025-12
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
AstraZeneca USD 1.55B 28K 2026-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Coherus Biosciences USD 121.16M 4.92M 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Halozyme Therapeutics USD 113.94M 106K 2026-09
Illumina USD 151.3M 607K 2026-06
Insmed USD 218.28M 1.76M 2026-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
J&J USD 2.41B 1.64M 2026-06
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
MacroGenics USD 63.65M 86K 2026-06
MannKind USD 321.63M 11.72M 2026-09
Merck USD 2.47B 1.05M 2026-06
Moderna USD 391M 2M 2025-09
Novartis USD 1.89B 12.09M 2026-09
PTC Therapeutics USD 83.33M 445K 2026-06
Puma Biotechnology USD 5K 0 2024-06
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
Thermo Fisher Scientific USD 369.75M 1.88M 2026-09
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
United Therapeutics USD 42.38M 295K 2026-09
Vanda Pharmaceuticals USD 58K 0 2024-12